{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:41:50Z","timestamp":1740123710196,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100011541","name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA2014"],"award-info":[{"award-number":["P30 CA2014"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s10689-022-00318-9","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T07:14:58Z","timestamp":1665558898000},"page":"217-224","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A need to tailor surveillance based on family history: describing a highly penetrant familial paraganglioma kindred with an SDHD pathogenic variant"],"prefix":"10.1007","volume":"22","author":[{"given":"Madeline","family":"Foley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anu","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinley","family":"Garfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke","family":"Maese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke","family":"Buchmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Kohlmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Jeter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4994-4793","authenticated-orcid":false,"given":"Samantha","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,12]]},"reference":[{"issue":"6","key":"318_CR1","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1136\/jmedgenet-2017-105127","volume":"55","author":"KA Andrews","year":"2018","unstructured":"Andrews KA, Ascher DB, Pires DEV et al (2018) Tumour risks and genotype\u2013phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB SDHC and SDHD. J Med Genet 55(6):384\u2013394","journal-title":"J Med Genet"},{"key":"318_CR2","unstructured":"Else T, Greenberg S, Fishbein L (1993) Hereditary Paraganglioma-Pheochromocytoma Syndromes. In: Adam MP, Everman DB, Mirzaa GM et al (eds) GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132022. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1548\/?report=classic"},{"issue":"1\u20132","key":"318_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergen.2012.01.009","volume":"205","author":"L Fishbein","year":"2012","unstructured":"Fishbein L, Nathanson KL (2012) Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background cancer. Genet 205(1\u20132):1\u201311. https:\/\/doi.org\/10.1016\/j.cancergen.2012.01.009","journal-title":"Genet"},{"issue":"1","key":"318_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/humu.21136","volume":"31","author":"CJ Ricketts","year":"2010","unstructured":"Ricketts CJ, Forman JR, Rattenberry E et al (2010) Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Hum Mutat 31(1):41\u201351. https:\/\/doi.org\/10.1002\/humu.21136","journal-title":"Hum Mutat"},{"issue":"8","key":"318_CR5","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jama.292.8.943","volume":"292","author":"HP Neumann","year":"2004","unstructured":"Neumann HP, Pawlu C, Peczkowska M et al (2004) Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292(8):943\u2013951. https:\/\/doi.org\/10.1001\/jama.292.8.943","journal-title":"JAMA"},{"issue":"1","key":"318_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/ajmg.c.30018","volume":"129C","author":"BE Baysal","year":"2004","unstructured":"Baysal BE (2004) Genomic imprinting and environment in hereditary paraganglioma. Am J Med Genet C Semin Med Genet 129C(1):85\u201390. https:\/\/doi.org\/10.1002\/ajmg.c.30018","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"11","key":"318_CR7","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1136\/jmedgenet-2018-105427","volume":"55","author":"DE Benn","year":"2018","unstructured":"Benn DE, Zhu Y, Andrews KA et al (2018) Bayesian approach to determining penetrance of pathogenic SDH variants. J Med Genet 55(11):729\u2013734","journal-title":"J Med Genet"},{"issue":"3","key":"318_CR8","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1210\/jc.2005-1862","volume":"91","author":"DE Benn","year":"2006","unstructured":"Benn DE, Gimenez-Roqueplo AP, Reilly JR et al (2006) Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes. J Clin Endocrinol Metab 91(3):827\u2013836. https:\/\/doi.org\/10.1210\/jc.2005-1862","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"318_CR9","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1210\/jc.2012-2975","volume":"98","author":"A-P Gimenez-Roqueplo","year":"2013","unstructured":"Gimenez-Roqueplo A-P, Caumont-Prim A, Houzard C et al (2013) Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA investigators. J Clin Endocrinol Metab 98(1):162\u2013173. https:\/\/doi.org\/10.1210\/jc.2012-2975","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"318_CR10","doi-asserted-by":"publisher","first-page":"e1301","DOI":"10.1210\/clinem\/dgaa888","volume":"106","author":"C Saie","year":"2020","unstructured":"Saie C, Buffet A, Abeillon J et al (2020) Screening of a large cohort of asymptomatic SDHx mutation carriers in routine practice. J Clin Endocrinol Metab 106(3):e1301\u2013e1315. https:\/\/doi.org\/10.1210\/clinem\/dgaa888","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"318_CR11","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41574-021-00492-3","volume":"17","author":"L Amar","year":"2021","unstructured":"Amar L, Pacak K, Steichen O et al (2021) International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers. Nat Rev Endocrinol 17(7):435\u2013444. https:\/\/doi.org\/10.1038\/s41574-021-00492-3","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"318_CR12","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1158\/1078-0432.CCR-17-0547","volume":"23","author":"SP Rednam","year":"2017","unstructured":"Rednam SP, Erez A, Druker H et al (2017) Von hippel-lindau and hereditary pheochromocytoma\/paraganglioma syndromes: clinical features, genetics, and surveillance recommendations in childhood. Clin Cancer Res 23(12):e68\u2013e75. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0547","journal-title":"Clin Cancer Res"},{"issue":"5","key":"318_CR13","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/coa.13782","volume":"46","author":"M Koenighofer","year":"2021","unstructured":"Koenighofer M, Parzefall T, Frohne A et al (2021) Incomplete penetrance of a novel SDHD variation causing familial head and neck paraganglioma. Clin Otolaryngol 46(5):1044\u20131049. https:\/\/doi.org\/10.1111\/coa.13782","journal-title":"Clin Otolaryngol"},{"issue":"2","key":"318_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10689-013-9639-6","volume":"13","author":"KW Jasperson","year":"2014","unstructured":"Jasperson KW, Kohlmann W, Gammon A et al (2014) Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families. Fam Cancer 13(2):257\u2013265. https:\/\/doi.org\/10.1007\/s10689-013-9639-6","journal-title":"Fam Cancer"},{"issue":"6","key":"318_CR15","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1530\/EJE-16-0595","volume":"175","author":"E Daniel","year":"2016","unstructured":"Daniel E, Jones R, Bull M, Newell-Price J (2016) Rapid-sequence MRI for long-term surveillance for paraganglioma and phaeochromocytoma in patients with succinate dehydrogenase mutations. Eur J Endocrinol 175(6):561\u2013570. https:\/\/doi.org\/10.1530\/EJE-16-0595","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"318_CR16","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1210\/js.2017-00230","volume":"1","author":"N Tufton","year":"2017","unstructured":"Tufton N, Sahdev A, Akker SA (2017) Radiological Surveillance Screening in Asymptomatic Succinate Dehydrogenase Mutation Carriers. Journal of the Endocrine Society 1(7):897\u2013907. https:\/\/doi.org\/10.1210\/js.2017-00230","journal-title":"Journal of the Endocrine Society"},{"issue":"15_suppl","key":"318_CR17","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1200\/JCO.2020.38.15_suppl.1545","volume":"38","author":"S Greenberg","year":"2020","unstructured":"Greenberg S, Jacobs M, Wachtel H et al (2020) Tumor detection rates in screening carriers with SDHx-related hereditary paraganglioma-pheochromocytoma syndrome based on prior tumor history. J Clin Oncol 38(15_suppl):1545\u20131545. https:\/\/doi.org\/10.1200\/JCO.2020.38.15_suppl.1545","journal-title":"J Clin Oncol"},{"issue":"1","key":"318_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1530\/EJE-10-0114","volume":"163","author":"N Van Duinen","year":"2010","unstructured":"Van Duinen N, Steenvoorden D, Bonsing B et al (2010) Pheochromocytomas detected by biochemical screening in predisposed subjects are associated with lower prevalence of clinical and biochemical manifestations and smaller tumors than pheochromocytomas detected by signs and symptoms. Eur J Endocrinol 163(1):121\u2013127","journal-title":"Eur J Endocrinol"},{"key":"318_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14184","author":"RG Martins","year":"2020","unstructured":"Martins RG, Cunha N, Simoes H et al (2020) Surveillance of succinate dehydrogenase gene mutation carriers: insights from a nationwide cohort. Clin Endocrinol. https:\/\/doi.org\/10.1111\/cen.14184","journal-title":"Clin Endocrinol"},{"issue":"1","key":"318_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/cen.13877","volume":"90","author":"N Tufton","year":"2019","unstructured":"Tufton N, Sahdev A, Drake WM, Akker SA (2019) Can subunit-specific phenotypes guide surveillance imaging decisions in asymptomatic SDH mutation carriers? Clin Endocrinol 90(1):31\u201346. https:\/\/doi.org\/10.1111\/cen.13877","journal-title":"Clin Endocrinol"},{"issue":"2","key":"318_CR21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/jmedgenet-2019-106214","volume":"57","author":"JP Bayley","year":"2020","unstructured":"Bayley JP, Bausch B, Rijken JA et al (2020) Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma-paraganglioma. J Med Genet 57(2):96\u2013103. https:\/\/doi.org\/10.1136\/jmedgenet-2019-106214","journal-title":"J Med Genet"},{"issue":"8","key":"318_CR22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/sj.ejhg.5200829","volume":"10","author":"A Cascon","year":"2002","unstructured":"Cascon A, Ruiz-Llorente S, Cebrian A et al (2002) Identification of novel SDHD mutations in patients with phaeochromocytoma and\/or paraganglioma. Eur J Hum Genet 10(8):457\u2013461. https:\/\/doi.org\/10.1038\/sj.ejhg.5200829","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"318_CR23","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1365-2265.2007.03086.x","volume":"68","author":"HJ Timmers","year":"2008","unstructured":"Timmers HJ, Pacak K, Bertherat J et al (2008) Mutations associated with succinate dehydrogenase D-related malignant paragangliomas. Clin Endocrinol 68(4):561\u2013566. https:\/\/doi.org\/10.1111\/j.1365-2265.2007.03086.x","journal-title":"Clin Endocrinol"},{"issue":"2","key":"318_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/01.pas.0000158987.07907.7e","volume":"14","author":"A Velasco","year":"2005","unstructured":"Velasco A, Palomar-Asenjo V, Ganan L et al (2005) Mutation analysis of the SDHD gene in four kindreds with familial paraganglioma: description of one novel germline mutation. Diagn Mol Pathol 14(2):109\u2013114","journal-title":"Diagn Mol Pathol"},{"key":"318_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-021-00492-3","author":"L Amar","year":"2021","unstructured":"Amar L, Pacak K, Steichen O et al (2021) International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers. Nat Rev Endocrinol. https:\/\/doi.org\/10.1038\/s41574-021-00492-3","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"318_CR26","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1210\/jc.2018-02411","volume":"104","author":"A Buffet","year":"2019","unstructured":"Buffet A, Ben Aim L, Leboulleux S et al (2019) Positive impact of genetic test on the management and outcome of patients with paraganglioma and\/or pheochromocytoma. J Clin Endocrinol Metab 104(4):1109\u20131118. https:\/\/doi.org\/10.1210\/jc.2018-02411","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-022-00318-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-022-00318-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-022-00318-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T09:21:21Z","timestamp":1678958481000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-022-00318-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,12]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["318"],"URL":"https:\/\/doi.org\/10.1007\/s10689-022-00318-9","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"type":"print","value":"1389-9600"},{"type":"electronic","value":"1573-7292"}],"subject":[],"published":{"date-parts":[[2022,10,12]]},"assertion":[{"value":"24 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors do not report any conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This manuscript is approved by the University of Utah IRB#00046740.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}